2m 2m 2m 2m 2m 2m 2m
LYELL IMMUNPHRM (LYEL)
NASDAQ
$14.32-$0.010 (-0.07%)
Price as of Jul 14, 2026 7:50 AM EDT- $334.4MMarket Cap
- 48.19%1-Year Change
- BiotechnologyIndustry
LYELL IMMUNPHRM (LYEL)
$14.32-$0.010 (-0.07%)
LYEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.33 | ||
Change | -$0.68 (-4.53%) | ||
Open | $14.79 | ||
High | $14.79 | ||
Low | $14.14 | ||
Previous Close | $15.01 | ||
Volume | 132,992 | ||
30-Day Average Volume | 273,566 | ||
1-Week Change | 2.07% | ||
1-Month Change | 6.15% | ||
1-Year Change | 48.19% | ||
3-Year Change | -77.11% | ||
5-Year Change | -95.58% | ||
Fundamentals | |||
Shares Outstanding | 23.3M | ||
Total Assets | $350.6M | ||
Market Cap | $334.4M | ||
Enterprise Value | $243.6M | ||
Period: QTR TTM FY | |||
Revenue | $2,000.00 | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$38.6M | ||
EBIT | -$24.2M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $230.4M | ||
EPS | -$1.10 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 121,804 | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 06/02/2025 | ||
Earnings & Revenue